TNF and COVID-19: In this respect, there is evidence that O2–O3 therapy can counteract chronic inflammation by reducing the circulating levels of the main pro-inflammatory cytokines IL-6, IL-2, IL-8, IFN-γ, TNF-α, and IL-1β in a variety of disease contexts, including COVID-19 [6,35,115,116,117,118].